|
 |
|
|||||||
|
|||||||||
Diabetes 52:2160-2167, 2003
© 2003 by the American Diabetes Association, Inc.
Prevalence and Characteristics of the Metabolic Syndrome in the San Antonio Heart and Framingham Offspring Studies
1 Department of Medicine, General Medicine Division, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
2 Boston University School of Medicine and Framingham Heart Study, Framingham, Massachusetts
3 Diabetes Unit, Department of Medicine, Massachusetts Hospital and Harvard Medical School, Boston, Massachusetts
4 Department of Mathematics, Statistics, and Consulting Unit, Boston University, Boston, Massachusetts
5 Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center, San Antonio, Texas
The metabolic syndrome may be a common phenotype increasing risk for type 2 diabetes and cardiovascular disease. We assessed the prevalence and characteristics of the metabolic syndrome among population-based samples of 3,224 white subjects attending Framingham Offspring Study (FOS) exam 5 (1991–1995) and 1,081 non-Hispanic white and 1,656 Mexican-American subjects attending the San Antonio Heart Study (SAHS) phase II follow-up exam (1992–1996). Subjects were 
50% women, aged 30–79 years, without diabetes, and classified with the metabolic syndrome according to criteria for obesity, dyslipidemia, hyperglycemia, and hypertension proposed by the Third Report of the National Cholesterol Education Program’s Adult Treatment Panel (ATP III) or the World Health Organization (WHO). We used regression models to estimate rates across ethnic groups and to assess the association of the metabolic syndrome with insulin resistance and predicted 10-year coronary heart disease (CHD) risk. Among FOS white subjects, the age- and sex-adjusted prevalence of the metabolic syndrome was 24% by both ATP III and WHO criteria; among SAHS non-Hispanic white subjects, 23 and 21%, respectively; and among SAHS Mexican-American subjects, 31 and 30%. Rates were highest among Mexican-American women (ATP III, 33%) and lowest among white women (21%). Subjects with the metabolic syndrome by ATP III criteria had higher age-, sex-, and ethnicity-adjusted levels of fasting insulin (11.3 µU/ml), homeostasis model assessment of insulin resistance (2.7), and predicted CHD risk (11.8%) than those without the syndrome (5.9 µU/ml, 1.3, and 6.4%, respectively; all P = 0.0001); differences were similar using WHO criteria. We conclude that the metabolic syndrome typically affects 20–30% of middle-aged adults in the U.S. By any criteria, subjects with the metabolic syndrome are more insulin resistant and at increased predicted risk for CHD versus those without the metabolic syndrome.
Address correspondence and reprint requests to James B. Meigs, MD, MPH, General Internal Medicine Unit, Massachusetts General Hospital, 50 Staniford St., 9th Fl., Boston, MA 02114. E-mail: jmeigs{at}partners.org
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  C. S. Blaum, N. A. West, and M. N. Haan Is the Metabolic Syndrome, With or Without Diabetes, Associated With Progressive Disability in Older Mexican Americans? J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2007; 62(7): 766 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Porrini, M. D. Gomez, A. Alvarez, M. Cobo, J. M. Gonzalez-Posada, L. Perez, L. Hortal, J. J. Garcia, M. Dolores Checa, A. Morales, et al. Glycated haemoglobin levels are related to chronic subclinical inflammation in renal transplant recipients without pre-existing or new onset diabetes Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1994 - 1999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Goodman, S. R. Daniels, J. B. Meigs, and L. M. Dolan Instability in the Diagnosis of Metabolic Syndrome in Adolescents Circulation, May 1, 2007; 115(17): 2316 - 2322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Sun, G. D. Grave, R. M. Siervogel, A. A. Pickoff, S. S. Arslanian, and S. R. Daniels Systolic Blood Pressure in Childhood Predicts Hypertension and Metabolic Syndrome Later in Life Pediatrics, February 1, 2007; 119(2): 237 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Mancia, M. Bombelli, G. Corrao, R. Facchetti, F. Madotto, C. Giannattasio, F. Q. Trevano, G. Grassi, A. Zanchetti, and R. Sega Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis Hypertension, January 1, 2007; 49(1): 40 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Maggi, M. Noale, P. Gallina, D. Bianchi, C. Marzari, F. Limongi, G. Crepaldi, and for the ILSA Working Group Metabolic syndrome, diabetes, and cardiovascular disease in an elderly caucasian cohort: the italian longitudinal study on aging. J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2006; 61(5): 505 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ma, Y. Li, D. E. Chiriboga, B. C. Olendzki, J. R. Hebert, W. Li, K. Leung, A. R. Hafner, and I. S. Ockene Association between Carbohydrate Intake and Serum Lipids. J. Am. Coll. Nutr., April 1, 2006; 25(2): 155 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Smith, H. Lee, and D. M. Nathan Insulin Sensitivity during Combined Androgen Blockade for Prostate Cancer J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1305 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R Christ, M. Zehnder, C. Boesch, R. Trepp, P. E Mullis, P. Diem, and J. Decombaz The effect of increased lipid intake on hormonal responses during aerobic exercise in endurance-trained men. Eur. J. Endocrinol., March 1, 2006; 154(3): 397 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lorenzo, M. Serrano-Rios, M. T. Martinez-Larrad, J. L. Gonzalez-Sanchez, S. Seclen, A. Villena, C. Gonzalez-Villalpando, K. Williams, and S. M. Haffner Geographic Variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III Definitions of the Metabolic Syndrome in Nondiabetic Subjects. Diabetes Care, March 1, 2006; 29(3): 685 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Eberly, R. Prineas, J. D. Cohen, G. Vazquez, X. Zhi, J. D. Neaton, L. H. Kuller, and for the Multiple Risk Factor Intervention Trial Re Metabolic Syndrome: Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial Diabetes Care, January 1, 2006; 29(1): 123 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Khunti and M. Davies Metabolic syndrome BMJ, November 19, 2005; 331(7526): 1153 - 1154. [Full Text] [PDF]
|
|
|
|
|
|
S. M. Grundy, J. I. Cleeman, S. R. Daniels, K. A. Donato, R. H. Eckel, B. A. Franklin, D. J. Gordon, R. M. Krauss, P. J. Savage, S. C. Smith Jr, et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation, October 25, 2005; 112(17): 2735 - 2752. [Full Text] [PDF]
|
|
|
|
|
|
R. Kahn, J. Buse, E. Ferrannini, and M. Stern The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care, September 1, 2005; 28(9): 2289 - 2304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Girman, J. M. Dekker, T. Rhodes, G. Nijpels, C. D. A. Stehouwer, L. M. Bouter, and R. J. Heine An Exploratory Analysis of Criteria for the Metabolic Syndrome and Its Prediction of Long-term Cardiovascular Outcomes: The Hoorn Study Am. J. Epidemiol., September 1, 2005; 162(5): 438 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Knudson, U. D. Dincer, G. M. Dick, H. Shibata, R. Akahane, M. Saito, and J. D. Tune Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1038 - H1046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.A. Lteif, K. Han, and K.J. Mather Obesity, Insulin Resistance, and the Metabolic Syndrome: Determinants of Endothelial Dysfunction in Whites and Blacks Circulation, July 5, 2005; 112(1): 32 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dokras, M. Bochner, E. Hollinrake, S. Markham, B. VanVoorhis, and D. H. Jagasia Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome Obstet. Gynecol., July 1, 2005; 106(1): 131 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bruckert, R. Pamphile, F. McCoy, and P. Andre Defining the prevalence of low HDL-C in a European cohort of dyslipidaemic patients Eur. Heart J. Suppl., July 1, 2005; 7(suppl_F): F23 - F26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sone, S. Mizuno, H. Fujii, Y. Yoshimura, Y. Yamasaki, S. Ishibashi, S. Katayama, Y. Saito, H. Ito, Y. Ohashi, et al. Is the Diagnosis of Metabolic Syndrome Useful for Predicting Cardiovascular Disease in Asian Diabetic Patients?: Analysis from the Japan Diabetes Complications Study Diabetes Care, June 1, 2005; 28(6): 1463 - 1471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nuver, A. J. Smit, B. H.R. Wolffenbuttel, W. J. Sluiter, H. J. Hoekstra, D. T. Sleijfer, and J. A. Gietema The Metabolic Syndrome and Disturbances in Hormone Levels in Long-Term Survivors of Disseminated Testicular Cancer J. Clin. Oncol., June 1, 2005; 23(16): 3718 - 3725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G D Kolovou, K K Anagnostopoulou, and D V Cokkinos Pathophysiology of dyslipidaemia in the metabolic syndrome Postgrad. Med. J., June 1, 2005; 81(956): 358 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Scuteri, S. S. Najjar, C. H. Morrell, and E. G. Lakatta The Metabolic Syndrome in Older Individuals: Prevalence and Prediction of Cardiovascular Events: The Cardiovascular Health Study Diabetes Care, April 1, 2005; 28(4): 882 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Apridonidze, P. A. Essah, M. J. Iuorno, and J. E. Nestler Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 1929 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Irace, C. Cortese, E. Fiaschi, C. Carallo, G. Sesti, E. Farinaro, and A. Gnasso Components of the Metabolic Syndrome and Carotid Atherosclerosis: Role of Elevated Blood Pressure Hypertension, April 1, 2005; 45(4): 597 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Maumus, B. Marie, G. Siest, and S. Visvikis-Siest A Prospective Study on the Prevalence of Metabolic Syndrome Among Healthy French Families: Two cardiovascular risk factors (HDL cholesterol and tumor necrosis factor-{alpha}) are revealed in the offspring of parents with metabolic syndrome Diabetes Care, March 1, 2005; 28(3): 675 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. McNeill, W. D. Rosamond, C. J. Girman, S. H. Golden, M. I. Schmidt, H. E. East, C. M. Ballantyne, and G. Heiss The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study Diabetes Care, February 1, 2005; 28(2): 385 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jerico, H. Knobel, M. Montero, J. Ordonez-Llanos, A. Guelar, J. L. Gimeno, P. Saballs, J. L. Lopez-Colomes, and J. Pedro-Botet Metabolic Syndrome Among HIV-Infected Patients: Prevalence, characteristics, and related factors Diabetes Care, January 1, 2005; 28(1): 132 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Simmons and C. F. Thompson Prevalence of the Metabolic Syndrome Among Adult New Zealanders of Polynesian and European Descent Diabetes Care, December 1, 2004; 27(12): 3002 - 3004. [Full Text] [PDF]
|
|
|
|
|
|
H. S. Lim, G. Y. H. Lip, and A. D. Blann Plasma von Willebrand Factor and the Development of the Metabolic Syndrome in Patients with Hypertension J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5377 - 5381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bruno, F. Merletti, A. Biggeri, G. Bargero, S. Ferrero, C. Runzo, S. Prina Cerai, G. Pagano, and P. Cavallo-Perin Metabolic Syndrome as a Predictor of All-Cause and Cardiovascular Mortality in Type 2 Diabetes: The Casale Monferrato Study Diabetes Care, November 1, 2004; 27(11): 2689 - 2694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Ford, W. H. Giles, and A. H. Mokdad Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults Diabetes Care, October 1, 2004; 27(10): 2444 - 2449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C.Y. Ng, W.-Y. So, V. K.L. Lam, C. S. Cockram, G. I. Bell, N. J. Cox, and J. C.N. Chan Genome-wide Scan for Metabolic Syndrome and Related Quantitative Traits in Hong Kong Chinese and Confirmation of a Susceptibility Locus on Chromosome 1q21-q25 Diabetes, October 1, 2004; 53(10): 2676 - 2683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Reilly, M. L. Wolfe, T. Rhodes, C. Girman, N. Mehta, and D. J. Rader Measures of Insulin Resistance Add Incremental Value to the Clinical Diagnosis of Metabolic Syndrome in Association With Coronary Atherosclerosis Circulation, August 17, 2004; 110(7): 803 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Carr and J. D. Brunzell Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2601 - 2607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs, K. Williams, L. M. Sullivan, K. J. Hunt, S. M. Haffner, M. P. Stern, C. Gonzalez Villalpando, J. S. Perhanidis, D. M. Nathan, R. B. D'Agostino Jr, et al. Using Metabolic Syndrome Traits for Efficient Detection of Impaired Glucose Tolerance Diabetes Care, June 1, 2004; 27(6): 1417 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-E. Tan, S. Ma, D. Wai, S.-K. Chew, and E.-S. Tai Can We Apply the National Cholesterol Education Program Adult Treatment Panel Definition of the Metabolic Syndrome to Asians? Diabetes Care, May 1, 2004; 27(5): 1182 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.C. Shoulders, E.L. Jones, and R.P. Naoumova Genetics of familial combined hyperlipidemia and risk of coronary heart disease Hum. Mol. Genet., April 1, 2004; 13(90001): R149 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Tonkin The metabolic syndrome - a growing problem Eur. Heart J. Suppl., March 1, 2004; 6(suppl_A): A37 - A42. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |